Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2025-12-26 @ 11:13 PM
Study NCT ID:
NCT02479412
Status:
COMPLETED
Last Update Posted:
2018-02-15
First Post:
2015-06-17
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06-25
Start Date Type:
ACTUAL
Primary Completion Date:
2016-02-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-02-08
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-17
First Submit QC Date:
None
Study First Post Date:
2015-06-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-01-27
Results First Submit QC Date:
None
Results First Post Date:
2017-06-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-28
Last Update Post Date:
2018-02-15
Last Update Post Date Type:
ACTUAL